Trade Setup Buy Target $4.05 Sell Target $4.79 Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs in the United States. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in blood plasma and other bodily fluids.
Read MoreBuy Target $7.40 or better Sell Target – TradersPro Sell Signal Communications Systems, Inc., through its subsidiaries, manufactures and sells connectivity infrastructure products for broadband and voice communications in North America, Europe, the Middle East, Africa, and internationally. The company’s Transition Networks segment designs, assembles, and markets media converters, NIDs, network interface cards, Ethernet switches, […]
Read MorePlus, it’s merger Monday, Uber lost its license to operate in London, and Tesla has 200,000 preorders for its Cybertruck.
Read MoreOne of the challenges all businesses face is their ability to remain relevant over time. Market economies are incredibly competitive, and that means that no matter what industry a business exists in, there is a constant need to adapt and change with the times. A good current example of what I mean exists in world […]
Read More